Bicara Therapeutics Inc.
BCAX
$11.32
-$0.52-4.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 114.17% | 100.51% | 112.51% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 250.36% | -- | 2,305.63% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 115.64% | -- | 117.48% | -- | -- |
|
|
|||||
| Total Current Assets | 115.64% | -- | 117.48% | -- | -- |
| Net Property, Plant & Equipment | 280.29% | -- | 3.68% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 227.68% | -- | 216.05% | -- | -- |
| Total Assets | 117.25% | -- | 117.96% | -- | -- |
|
|
|||||
| Total Accounts Payable | -37.84% | -- | 41.49% | -- | -- |
| Total Accrued Expenses | 19.48% | -- | 10.86% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 258.00% | -- | 112.98% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.23% | -- | 19.26% | -- | -- |
|
|
|||||
| Total Current Liabilities | 7.23% | -- | 19.26% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 436.41% | -- | -64.78% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.95% | -- | 17.11% | -- | -- |
|
|
|||||
| Common Stock & APIC | 9,134.12% | -- | 16,666.02% | -- | -- |
| Retained Earnings | -56.23% | -- | -44.44% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 349.00% | 408.50% | 430.63% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 349.00% | 408.50% | 430.63% | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.07% | 110.04% | 125.11% | -- | -- |
|
|
|||||